Calcium-dependent acetylcholine release

Calcium-dependent acetylcholine release at the neuromuscular junction (NMJ) is the physiological process that converts an electrical motor neuron signal into skeletal muscle contraction [1]. This mechanism is initiated by the arrival of an action potential at the presynaptic terminal, which triggers the opening of voltage-gated P/Q-type calcium channels (VGCCs) and a subsequent influx of calcium ions [2]. The rising intracellular calcium is sensed by synaptotagmin-1, which then promotes the fusion of acetylcholine-containing synaptic vesicles with the presynaptic plasma membrane [1]. This fusion is mediated by the assembly of the SNARE protein complex, which includes SNAP-25, syntaxin-1, and synaptobrevin-2 [5]. This process is a major site of pathology in several neuromuscular disorders [4]. For instance, in Lambert-Eaton myasthenic syndrome, autoantibodies target the P/Q-type VGCCs, reducing the calcium influx necessary for neurotransmitter release [4]. Additionally, Botulinum neurotoxins act by enzymatically cleaving specific SNARE proteins, thereby blocking the exocytosis of acetylcholine and causing paralysis [5]. Therapeutic strategies targeting this pathway include the use of amifampridine, a potassium channel blocker that prolongs presynaptic depolarization [3]. By extending the duration of the action potential, amifampridine enhances calcium entry and helps restore acetylcholine release in compromised junctions [3]. Understanding this complex machinery is vital for developing treatments for both autoimmune and toxin-mediated neuromuscular failure.

Other names

Presynaptic acetylcholine releaseNeurotransmitter exocytosis at the neuromuscular junctionCalcium-triggered synaptic vesicle fusion

Amifampridine blocks presynaptic potassium channels to prolong depolarization and increase calcium influx through P/Q-type channels [3]. Botulinum toxins act as endopeptidases that cleave SNARE proteins (SNAP-25, syntaxin, or synaptobrevin), preventing vesicle fusion and acetylcholine release [5].